434 related articles for article (PubMed ID: 28982308)
1. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
2. Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia.
Jamalpour M; Li X; Gustafsson K; Tyner JW; Welsh M
Tumour Biol; 2018 Apr; 40(4):1010428318771472. PubMed ID: 29792386
[TBL] [Abstract][Full Text] [Related]
3. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
4. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
6. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
[TBL] [Abstract][Full Text] [Related]
7. Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Kapelko-Slowik K; Owczarek TB; Grzymajlo K; Urbaniak-Kujda D; Jazwiec B; Slowik M; Kuliczkowski K; Ugorski M
Leuk Lymphoma; 2016 Sep; 57(9):2140-9. PubMed ID: 26764044
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract][Full Text] [Related]
9. The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.
Wampfler J; Federzoni EA; Torbett BE; Fey MF; Tschan MP
Leuk Res; 2016 Feb; 41():96-102. PubMed ID: 26740055
[TBL] [Abstract][Full Text] [Related]
10. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
[TBL] [Abstract][Full Text] [Related]
11. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
13. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
14. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
[TBL] [Abstract][Full Text] [Related]
15. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
16. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of cancer-related galectins in acute myeloid leukemia.
El Leithy AA; Helwa R; Assem MM; Hassan NH
Tumour Biol; 2015 Sep; 36(10):7929-39. PubMed ID: 25953264
[TBL] [Abstract][Full Text] [Related]
18. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
[TBL] [Abstract][Full Text] [Related]
19. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
20. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]